Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression ; volume:50 ; number:1 ; year:2020 ; pages:130-137 ; extent:8
European journal of immunology ; 50, Heft 1 (2020), 130-137 (gesamt 8)
- Creator
-
McCarthy, Michael T.
Lin, Da
Soga, Tomoyoshi
Adam, Julie
O'Callaghan, Christopher A.
- DOI
-
10.1002/eji.201847948
- URN
-
urn:nbn:de:101:1-2022062707283257722200
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McCarthy, Michael T.
- Lin, Da
- Soga, Tomoyoshi
- Adam, Julie
- O'Callaghan, Christopher A.
Other Objects (12)
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Fc-optimierte NKG2D-Fusionsproteine zur Induktion von NK-Zell Reaktivität gegen Leukämien
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells
Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
EF24 exerts cytotoxicity against NSCLC via inducing ROS accumulation
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Fc-optimierte NKG2D-Fusionsproteine zur Induktion von NK-Zell Reaktivität gegen Leukämien
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells
Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
EF24 exerts cytotoxicity against NSCLC via inducing ROS accumulation
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors
Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Der NK-Zellrezeptor NKG2D als Zielstruktur für eine Antikörper-basierte therapeutische Immunmodulation
Fc-optimierte NKG2D-Fusionsproteine zur Induktion von NK-Zell Reaktivität gegen Leukämien
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells
Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients